Is Rapamycin a Rapalog?

Nutrition and Healthy Aging - Netherlands
doi 10.3233/nha-180045
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

The FKBP12-Rapamycin-binding Domain Is Required for FKBP12-Rapamycin-associated Protein Kinase Activity and G1Progression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2009English

Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

The 4e-Bp1/eIF4E Ratio Is a Determinant for Rapamycin Response in Esophageal Cancer Cells

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

Topical Rapamycin

Archives of Dermatology
2010English

Rapalog Combined With CCR4 Antagonist Improves Anticancer Vaccines Efficacy

International Journal of Cancer
Cancer ResearchOncology
2018English

Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate

Cancer Prevention Research
MedicineCancer ResearchOncology
2011English

MNK1 Pathway Activity Maintains Protein Synthesis in Rapalog-Treated Gliomas

Journal of Clinical Investigation
Medicine
2014English

Inflammation‐induced Mammalian Target of Rapamycin Signaling Is Essential for Retina Regeneration

GLIA
Molecular NeuroscienceNeurologyCellular
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy